July 2022 Issue Table Of Contents

From The Editor

• Scouting Turbulence For Opportunity

Feature Articles

• A Network and Pivot Model For Success In Cancer Drug Development

CEO Corner

• 5 Mistakes To Avoid When Scaling Your Biotech Startup

Companies To Watch

• Mirum Pharmaceuticals

Industry Research

• Phase 2/3 Service Provider Attributes Gaining In Selection Importance

Inside The Industry

• What To Consider When Acquiring A Biopharma Manufacturing Facility
• Biopharma In China: The Emerging Global Force Of Domestic Suppliers
• New Space For Bio In Transplantation
• Milestone Payments In Life Sciences M&A And Licensing Transactions
• Why You Shouldn’t Neglect The Pre-IND Meeting
• Transitioning To Orphan Drug Commercialization: A Q&A With Albireo Pharma’s CEO Ron Cooper
• What’s Next In Biotech’s Deal Playbook?
• 4 Trends Will Shape Life Sciences Executive And Board Recruitment

Industry Leader

• The Future Of Pharma Lies In Gaming Technologies
• Can AI/ML Help Solve Sex Bias In Clinical Trials?
• How Cell And Gene Therapies Are Advancing Collaborations In Biopharma

Leadership Lessons

• 3 Tips For Women To Develop A More Authentic Leadership Style

Ask The Board

• What Advice Would You Give To A First Time CEO?
• What Are The Most Important Questions To Ask, Or Factors To Consider, When Considering A New Collaboration?